193 related articles for article (PubMed ID: 28498352)
21. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
22. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
23. Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
Chae YN; Kim TH; Kim MK; Shin CY; Jung IH; Sohn YS; Son MH
PLoS One; 2015; 10(12):e0144064. PubMed ID: 26633898
[TBL] [Abstract][Full Text] [Related]
24. The plasma levels of atrial natriuretic peptide and brain natriuretic peptide in type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor.
Feng X; Gu Q; Gao G; Yuan L; Li Q; Zhang Y
Ann Endocrinol (Paris); 2020 Oct; 81(5):476-481. PubMed ID: 32822653
[TBL] [Abstract][Full Text] [Related]
25. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
26. Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database.
Mamza J; Mehta R; Donnelly R; Idris I
Diabetes Technol Ther; 2016 Feb; 18(2):85-92. PubMed ID: 26752504
[TBL] [Abstract][Full Text] [Related]
27. Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients.
Shao SC; Chang KC; Lin SJ; Chien RN; Hung MJ; Chan YY; Kao Yang YH; Lai EC
Cardiovasc Diabetol; 2020 Feb; 19(1):17. PubMed ID: 32050968
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles.
Huang Y; Zhao X; Zu Y; Wang L; Deng Y; Wu M; Wang H
Iran J Pharm Res; 2019; 18(1):168-182. PubMed ID: 31089353
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the antidiabetic effects of dipeptidyl peptidase-IV inhibitor ASP8497 in streptozotocin-nicotinamide-induced mildly diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Pharmacology; 2009; 83(3):177-87. PubMed ID: 19176982
[TBL] [Abstract][Full Text] [Related]
30. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
[TBL] [Abstract][Full Text] [Related]
31. The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.
Avogaro A; Fadini GP
Diabetes Care; 2014 Oct; 37(10):2884-94. PubMed ID: 25249673
[TBL] [Abstract][Full Text] [Related]
32. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
33. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
[TBL] [Abstract][Full Text] [Related]
34. Influence of Diet and Gender on Plasma DPP4 Activity and GLP-1 in Patients with Metabolic Syndrome: An Experimental Pilot Study.
Pérez-Durillo FT; Segarra AB; Villarejo AB; Ramírez-Sánchez M; Prieto I
Molecules; 2018 Jun; 23(7):. PubMed ID: 29958403
[TBL] [Abstract][Full Text] [Related]
35. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats.
Al-Ghamdi MA; Moselhy SS
Environ Sci Pollut Res Int; 2023 Mar; 30(12):33942-33948. PubMed ID: 36496522
[TBL] [Abstract][Full Text] [Related]
37. Glucose-Responsive Polyelectrolyte Complexes Based on Dendritic Mesoporous Silica for Oral Insulin Delivery.
Qin T; Yan L; Wang X; Lin S; Zeng Q
AAPS PharmSciTech; 2021 Aug; 22(7):226. PubMed ID: 34426942
[TBL] [Abstract][Full Text] [Related]
38. What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.
Elmansi AM; Awad ME; Eisa NH; Kondrikov D; Hussein KA; Aguilar-Pérez A; Herberg S; Periyasamy-Thandavan S; Fulzele S; Hamrick MW; McGee-Lawrence ME; Isales CM; Volkman BF; Hill WD
Pharmacol Ther; 2019 Jun; 198():90-108. PubMed ID: 30759373
[TBL] [Abstract][Full Text] [Related]
39. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.
Miyazaki M; Kato M; Tanaka K; Tanaka M; Kohjima M; Nakamura K; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R
Mol Med Rep; 2012 Mar; 5(3):729-33. PubMed ID: 22179204
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
